quinacrine and Adnexitis
quinacrine has been researched along with Adnexitis in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Adnexitis: Inflammation of the uterine appendages (ADNEXA UTERI) including infection of the FALLOPIAN TUBES (SALPINGITIS), the ovaries (OOPHORITIS), or the supporting ligaments (PARAMETRITIS).
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ectopic pregnancies and the occurrence of other adverse health events." | 1.31 | Long-term follow-up after quinacrine sterilization in Vietnam. Part II: interim safety analysis. ( Hanenberg, R; Hieu, DT; Huu Vach, T; Sokal, D; Vinh, DQ; Weiner, DH, 2000) |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Sokal, DC | 1 |
| Hieu, do T | 1 |
| Loan, ND | 1 |
| Hubacher, D | 1 |
| Nanda, K | 1 |
| Weiner, DH | 2 |
| Vach, TH | 1 |
| Sokal, D | 1 |
| Hieu, DT | 1 |
| Vinh, DQ | 1 |
| Huu Vach, T | 1 |
| Hanenberg, R | 1 |
Other Studies
2 other studies available for quinacrine and Adnexitis
| Article | Year |
|---|---|
Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam.
Topics: Adult; Age Factors; Cohort Studies; Drug Administration Schedule; Female; Follow-Up Studies; Humans; | 2008 |
Long-term follow-up after quinacrine sterilization in Vietnam. Part II: interim safety analysis.
Topics: Adult; Cohort Studies; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intrauterine | 2000 |